SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MEI'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_E_ESTE600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		4 / 8 ALA A 343
LEU A 380
ARG A 387
LEU A 507
 MEI  A1001 (-3.3A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-4.6A)
 0.95A 1ereE-1uhlA:
25.9		 1ereE-1uhlA:
31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_F_ESTF600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		4 / 8 ALA A 343
LEU A 380
ARG A 387
LEU A 507
 MEI  A1001 (-3.3A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-4.6A)
 0.96A 1ereF-1uhlA:
25.9		 1ereF-1uhlA:
31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERR_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
LEU A 347
TRP A 376
ARG A 387
ILE A 499
 MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.6A)
None
 1.13A 1errA-1uhlA:
22.2		 1errA-1uhlA:
31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERR_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 499
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.98A 1errB-1uhlA:
22.5		 1errB-1uhlA:
31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FBY_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
CYH A 340
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
HIS A 506
 MEI  A1001 (-3.8A)
None
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
None
 0.66A 1fbyA-1uhlA:
33.3		 1fbyA-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FBY_B_9CRB1500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
CYH A 340
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
HIS A 506
 MEI  A1001 (-3.8A)
None
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
None
 0.63A 1fbyB-1uhlA:
33.0		 1fbyB-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 342
ALA A 343
GLN A 346
TRP A 376
ALA A 398
LEU A 526
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.4A)
None
 1.19A 1fm6A-1uhlA:
33.7		 1fm6A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.62A 1fm6A-1uhlA:
33.7		 1fm6A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_U_9CRU502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 ALA A 342
ALA A 343
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
ILE A 416
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.65A 1fm6U-1uhlA:
33.7		 1fm6U-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_U_9CRU502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 TRP A 376
VAL A 413
ILE A 416
CYH A 503
HIS A 506
LEU A 507
 None
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 1.20A 1fm6U-1uhlA:
33.7		 1fm6U-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM9_A_9CRA201_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		7 / 12 ALA A 342
ALA A 343
TRP A 376
LEU A 380
ARG A 387
ALA A 398
LEU A 526
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
 1.36A 1fm9A-1uhlA:
34.2		 1fm9A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM9_A_9CRA201_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.58A 1fm9A-1uhlA:
34.2		 1fm9A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1G5Y_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 522
TRP A 376
ARG A 387
ALA A 398
ILE A 339
 None
None
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
MEI  A1001 (-3.8A)
 1.30A 1g5yB-1uhlA:
26.4		 1g5yB-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1G5Y_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 TRP A 376
LEU A 380
ARG A 387
LEU A 397
ALA A 398
 None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
 0.65A 1g5yB-1uhlA:
26.4		 1g5yB-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1G5Y_C_9CRC502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 10 LEU A 380
SER A 383
ARG A 387
LEU A 397
ALA A 398
ILE A 339
 MEI  A1001 (-3.8A)
None
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-3.8A)
 1.38A 1g5yC-1uhlA:
26.5		 1g5yC-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1G5Y_C_9CRC502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 10 LEU A 380
SER A 383
PHE A 384
ARG A 387
LEU A 397
ALA A 398
 MEI  A1001 (-3.8A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
 0.66A 1g5yC-1uhlA:
26.5		 1g5yC-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K74_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		7 / 12 ALA A 342
ALA A 343
TRP A 376
LEU A 380
ARG A 387
ALA A 398
LEU A 526
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
 1.40A 1k74A-1uhlA:
34.1		 1k74A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K74_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.60A 1k74A-1uhlA:
34.1		 1k74A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1QKN_A_RALA600_1
(ESTROGEN RECEPTOR
BETA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
LEU A 380
ARG A 387
ILE A 416
LEU A 507
 MEI  A1001 (-3.3A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
MEI  A1001 (-4.6A)
 0.92A 1qknA-1uhlA:
22.5		 1qknA-1uhlA:
31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1QKN_A_RALA600_1
(ESTROGEN RECEPTOR
BETA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
LEU A 380
ARG A 387
ILE A 499
GLY A 500
 MEI  A1001 (-3.3A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
None
 0.97A 1qknA-1uhlA:
22.5		 1qknA-1uhlA:
31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XDK_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
GLN A 346
TRP A 376
ASN A 377
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
None
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.61A 1xdkA-1uhlA:
35.2		 1xdkA-1uhlA:
87.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XDK_E_9CRE1500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.54A 1xdkE-1uhlA:
35.2		 1xdkE-1uhlA:
87.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XIU_A_9CRA201_1
(RXR-LIKE PROTEIN)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 CYH A 340
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 None
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.65A 1xiuA-1uhlA:
31.3		 1xiuA-1uhlA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XIU_A_9CRA201_1
(RXR-LIKE PROTEIN)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 ILE A 339
CYH A 340
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
 MEI  A1001 (-3.8A)
None
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
 0.60A 1xiuA-1uhlA:
31.3		 1xiuA-1uhlA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XIU_B_9CRB202_1
(RXR-LIKE PROTEIN)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
LEU A 380
PHE A 384
ARG A 387
ALA A 398
VAL A 413
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.56A 1xiuB-1uhlA:
34.9		 1xiuB-1uhlA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLS_A_9CRA801_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.57A 1xlsA-1uhlA:
34.7		 1xlsA-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLS_B_9CRB802_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.58A 1xlsB-1uhlA:
34.7		 1xlsB-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLS_C_9CRC803_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.57A 1xlsC-1uhlA:
34.7		 1xlsC-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLS_D_9CRD804_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.57A 1xlsD-1uhlA:
34.7		 1xlsD-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_A_REAA502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 ALA A 342
ALA A 343
GLN A 346
ASN A 377
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
 0.73A 2aclA-1uhlA:
30.0
2aclE-1uhlA:
30.0		 2aclA-1uhlA:
88.19
2aclE-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_C_REAC503_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 10 ILE A 339
ALA A 342
ALA A 343
GLN A 346
ASN A 377
PHE A 384
ARG A 387
ALA A 398
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
 0.83A 2aclC-1uhlA:
30.2		 2aclC-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_E_REAE504_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 11 ILE A 339
ALA A 342
ALA A 343
GLN A 346
ASN A 377
LEU A 380
PHE A 384
ARG A 387
ALA A 398
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
 0.89A 2aclE-1uhlA:
30.0		 2aclE-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_G_REAG501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
ASN A 377
LEU A 380
ILE A 381
PHE A 384
ARG A 387
LEU A 397
ALA A 398
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
 0.85A 2aclG-1uhlA:
29.1		 2aclG-1uhlA:
88.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ARG A 442
ILE A 499
ILE A 416
PHE A 417
ALA A 343
 None
None
None
None
MEI  A1001 (-3.3A)
 1.18A 2j0dA-1uhlA:
undetectable		 2j0dA-1uhlA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
LEU A 347
TRP A 376
LEU A 380
ARG A 387
ILE A 416
 MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.99A 2jfaA-1uhlA:
22.8		 2jfaA-1uhlA:
28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
LEU A 347
TRP A 376
LEU A 380
ARG A 387
ILE A 499
 MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 1.12A 2jfaA-1uhlA:
22.8		 2jfaA-1uhlA:
28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 416
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
MEI  A1001 (-4.6A)
 0.93A 2jfaA-1uhlA:
22.8		 2jfaA-1uhlA:
28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
GLY A 500
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.84A 2jfaB-1uhlA:
22.6		 2jfaB-1uhlA:
28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-4.6A)
 0.72A 2jfaB-1uhlA:
22.6		 2jfaB-1uhlA:
28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 347
TRP A 376
LEU A 380
ARG A 387
GLY A 500
 None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.91A 2jfaB-1uhlA:
22.6		 2jfaB-1uhlA:
28.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 416
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
MEI  A1001 (-4.6A)
 0.90A 2qxsA-1uhlA:
23.0		 2qxsA-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 499
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.98A 2qxsA-1uhlA:
23.0		 2qxsA-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 347
TRP A 376
LEU A 380
ARG A 387
ILE A 416
 None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 1.07A 2qxsA-1uhlA:
23.0		 2qxsA-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 347
TRP A 376
LEU A 380
ARG A 387
ILE A 499
 None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 1.12A 2qxsA-1uhlA:
23.0		 2qxsA-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 416
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
MEI  A1001 (-4.6A)
 0.89A 2qxsB-1uhlA:
22.8		 2qxsB-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 499
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.97A 2qxsB-1uhlA:
22.8		 2qxsB-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 347
TRP A 376
LEU A 380
ARG A 387
ILE A 416
 None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 1.09A 2qxsB-1uhlA:
22.8		 2qxsB-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_B_RALB600_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 347
TRP A 376
LEU A 380
ARG A 387
ILE A 499
 None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 1.13A 2qxsB-1uhlA:
22.8		 2qxsB-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZU_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
GLN A 346
ASN A 377
ILE A 381
PHE A 384
ARG A 387
LEU A 397
VAL A 413
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
None
None
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.72A 3dzuA-1uhlA:
33.2		 3dzuA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 342
GLN A 346
ASN A 377
ARG A 387
ALA A 398
LEU A 526
 MEI  A1001 (-3.1A)
None
None
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
 1.44A 3dzyA-1uhlA:
31.4		 3dzyA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 12 ALA A 342
GLN A 346
ASN A 377
PHE A 384
ARG A 387
LEU A 397
ALA A 398
CYH A 503
LEU A 507
 MEI  A1001 (-3.1A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.75A 3dzyA-1uhlA:
31.4		 3dzyA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 12 ALA A 342
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.1A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.78A 3dzyA-1uhlA:
31.4		 3dzyA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 12 ILE A 339
ALA A 342
GLN A 346
ASN A 377
PHE A 384
ARG A 387
LEU A 397
ALA A 398
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
 0.58A 3dzyA-1uhlA:
31.4		 3dzyA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 12 ILE A 339
ALA A 342
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
 0.57A 3dzyA-1uhlA:
31.4		 3dzyA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E00_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
ASN A 377
PHE A 384
ARG A 387
ALA A 398
VAL A 413
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
 0.72A 3e00A-1uhlA:
33.5		 3e00A-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FAL_A_REAA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 10 ILE A 339
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
ALA A 398
VAL A 413
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
 0.72A 3falA-1uhlA:
29.5		 3falA-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FAL_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 10 ILE A 339
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
 0.66A 3falC-1uhlA:
29.6		 3falC-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FC6_A_REAA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 11 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
 0.59A 3fc6A-1uhlA:
30.3		 3fc6A-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FC6_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 VAL A 336
ALA A 342
ALA A 343
GLN A 346
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
 None
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
 0.66A 3fc6C-1uhlA:
30.8		 3fc6C-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FC6_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 VAL A 336
CYH A 340
ALA A 342
ALA A 343
GLN A 346
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
 None
None
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
 0.59A 3fc6C-1uhlA:
30.8		 3fc6C-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 12 ALA A 342
ALA A 343
GLN A 346
TRP A 376
LEU A 380
ARG A 387
LEU A 397
ALA A 398
VAL A 413
LEU A 507
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.6A)
 0.79A 3h0aA-1uhlA:
32.0		 3h0aA-1uhlA:
88.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 12 ALA A 342
ALA A 343
TRP A 376
LEU A 380
ARG A 387
LEU A 397
ALA A 398
VAL A 413
ILE A 416
LEU A 507
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.6A)
 0.83A 3h0aA-1uhlA:
32.0		 3h0aA-1uhlA:
88.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		7 / 12 ALA A 342
LEU A 380
ARG A 387
LEU A 397
VAL A 413
ILE A 416
CYH A 503
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
 0.96A 3h0aA-1uhlA:
32.0		 3h0aA-1uhlA:
88.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_2
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		3 / 3 ILE A 339
PHE A 384
HIS A 506
 MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
None
 0.52A 3h0aA-1uhlA:
32.0		 3h0aA-1uhlA:
88.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OAP_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
ILE A 416
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.66A 3oapA-1uhlA:
36.0		 3oapA-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OAP_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ILE A 339
ALA A 343
GLN A 346
PHE A 384
VAL A 413
ILE A 416
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-4.1A)
None
 1.45A 3oapA-1uhlA:
36.0		 3oapA-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3Q95_A_ESLA700_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
LEU A 380
ARG A 387
ILE A 499
GLY A 500
 MEI  A1001 (-3.3A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
None
 1.03A 3q95A-1uhlA:
25.8		 3q95A-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3Q95_B_ESLB700_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
LEU A 380
ARG A 387
ILE A 499
GLY A 500
 MEI  A1001 (-3.3A)
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
None
 1.05A 3q95B-1uhlA:
25.2		 3q95B-1uhlA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UVV_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 12 ALA A 342
ALA A 343
GLN A 346
LEU A 380
PHE A 384
ARG A 387
ALA A 398
ILE A 416
CYH A 503
LEU A 507
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.52A 3uvvB-1uhlA:
36.0		 3uvvB-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UVV_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
LEU A 380
PHE A 384
ARG A 387
ALA A 398
VAL A 413
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
None
MEI  A1001 (-4.0A)
 0.50A 3uvvB-1uhlA:
36.0		 3uvvB-1uhlA:
88.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4K6I_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
LEU A 380
ILE A 381
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 420
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
 0.46A 4k6iA-1uhlA:
35.8		 4k6iA-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4K6I_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		8 / 12 ILE A 339
GLN A 346
ILE A 381
PHE A 384
ARG A 387
LEU A 397
ALA A 398
CYH A 503
 MEI  A1001 (-3.8A)
None
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
 0.91A 4k6iA-1uhlA:
35.8		 4k6iA-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4K6I_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 LEU A 380
ILE A 381
PHE A 384
ALA A 342
VAL A 420
 MEI  A1001 (-3.8A)
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.1A)
None
 1.03A 4k6iA-1uhlA:
35.8		 4k6iA-1uhlA:
88.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 11 ALA A 343
GLN A 346
PHE A 384
LEU A 397
ALA A 398
VAL A 413
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.67A 4nqaA-1uhlA:
33.8		 4nqaA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		8 / 11 ILE A 339
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
 0.70A 4nqaA-1uhlA:
33.8		 4nqaA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 11 ILE A 339
ALA A 343
GLN A 346
PHE A 384
LEU A 397
ALA A 398
VAL A 413
CYH A 503
HIS A 506
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
None
 0.63A 4nqaA-1uhlA:
33.8		 4nqaA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		8 / 12 ALA A 342
ALA A 343
ARG A 387
LEU A 397
ALA A 398
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.58A 4nqaH-1uhlA:
34.1		 4nqaH-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		8 / 12 ALA A 342
ALA A 343
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
LEU A 507
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.65A 4nqaH-1uhlA:
34.1		 4nqaH-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		10 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
CYH A 503
HIS A 506
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.0A)
None
 0.63A 4nqaH-1uhlA:
34.1		 4nqaH-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		9 / 12 ILE A 339
ALA A 342
ALA A 343
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
 0.72A 4nqaH-1uhlA:
34.1		 4nqaH-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
ASP A 344
TRP A 376
LEU A 380
ARG A 387
LEU A 507
 MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-4.6A)
 1.03A 4xi3B-1uhlA:
22.6		 4xi3B-1uhlA:
30.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		6 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
ILE A 499
GLY A 500
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
None
 1.04A 4xi3B-1uhlA:
22.6		 4xi3B-1uhlA:
30.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_C_29SC601_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
GLY A 500
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
None
 0.80A 4xi3C-1uhlA:
22.5		 4xi3C-1uhlA:
30.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_C_29SC601_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-4.6A)
 0.87A 4xi3C-1uhlA:
22.5		 4xi3C-1uhlA:
30.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_D_29SD601_1
(ESTROGEN RECEPTOR)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 12 ALA A 343
TRP A 376
LEU A 380
ARG A 387
LEU A 507
 MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.6A)
MEI  A1001 (-4.6A)
 0.84A 4xi3D-1uhlA:
22.8		 4xi3D-1uhlA:
30.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5JI0_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		5 / 11 GLN A 346
TRP A 376
LEU A 380
ALA A 398
LEU A 526
 None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-3.4A)
None
 1.15A 5ji0A-1uhlA:
34.0		 5ji0A-1uhlA:
87.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5JI0_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		11 / 11 ILE A 339
GLN A 346
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
None
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.56A 5ji0A-1uhlA:
34.0		 5ji0A-1uhlA:
87.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5UAN_A_9CRA503_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.77A 5uanA-1uhlA:
33.6		 5uanA-1uhlA:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5Z12_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
TRP A 376
LEU A 380
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.55A 5z12B-1uhlA:
35.6		 5z12B-1uhlA:
80.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5Z12_C_9CRC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
VAL A 413
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
MEI  A1001 (-4.1A)
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.66A 5z12C-1uhlA:
33.8		 5z12C-1uhlA:
80.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Y_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		7 / 12 ALA A 342
ALA A 343
GLN A 346
TRP A 376
ARG A 387
ALA A 398
LEU A 526
 MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
 1.31A 6a5yD-1uhlA:
35.5		 6a5yD-1uhlA:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Y_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.73A 6a5yD-1uhlA:
35.5		 6a5yD-1uhlA:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Y_D_9CRD501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		3 / 3 ASN A 377
VAL A 413
HIS A 506
 None
MEI  A1001 (-4.1A)
None
 0.67A 6a5yD-1uhlA:
35.5		 6a5yD-1uhlA:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Z_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
ILE A 381
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
 0.62A 6a5zD-1uhlA:
35.9		 6a5zD-1uhlA:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Z_L_9CRL501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.65A 6a5zL-1uhlA:
35.4		 6a5zL-1uhlA:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A60_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1uhl RETINOIC ACID
RECEPTOR RXR-BETA
(Homo
sapiens) 		12 / 12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
LEU A 380
PHE A 384
ARG A 387
ALA A 398
ILE A 416
CYH A 503
HIS A 506
LEU A 507
 MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 (-3.8A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
None
MEI  A1001 (-4.6A)
 0.65A 6a60D-1uhlA:
35.6		 6a60D-1uhlA:
79.75